Page 1 of Clinical Trials for ( Lymphoma AND T-Cell ), 948 Total Matches
- 1RecruitingLast Updated: November 10, 2009Condition(s): Peripheral T-cell Lymphoma (Not Otherwise Specified); Angioimmunoblastic T-cell Lymphoma; Extranodal NK/T-cell Lymphoma Nasal Type; Enteropathy- Type T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative); Relapsed ALCL (ALK-1 Positive) Post Autologous Transplant
- 2TerminatedLast Updated: November 2, 2011Condition(s): Cutaneous T-Cell Lymphoma; Leukemia-Lymphoma, Adult T-Cell
- 3Active, not recruitingLast Updated: March 14, 2012Condition(s): Cutaneous T Cell Lymphoma; Peripheral T Cell Lymphoma
- 4Active, not recruitingLast Updated: December 15, 2009Condition(s): Cutaneous T-Cell Lymphoma; Peripheral T-Cell Lymphoma; Non-Hodgkin's Lymphoma
- 5RecruitingLast Updated: June 30, 2011Condition(s): Lymphoma, T-Cell, Peripheral
- 6CompletedLast Updated: December 29, 2011Condition(s): Lymphoma, Large-Cell, Ki-1; Lymphoma, T-Cell
- 7RecruitingLast Updated: April 9, 2012Condition(s): Leukemia; Lymphoma
- 8Active, not recruitingLast Updated: January 18, 2012Condition(s): Cutaneous T-cell Lymphoma
- 9RecruitingLast Updated: May 22, 2012Condition(s): Peripheral T Cell Lymphoma Unspecified; Anaplastic Large Cell Lymphoma, ALK-negative; Angioimmunoblastic T Cell Lymphoma; Cutaneous T Cell Lymphoma
- 10Active, not recruitingLast Updated: May 22, 2012Condition(s): Lymphoma
- 11RecruitingLast Updated: July 21, 2011Condition(s): Enteropathy-Associated T-Cell Lymphoma; Anaplastic Large-Cell Lymphoma; Cutaneous T-Cell Lymphoma; Primary Cutaneous Anaplastic Large Cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Peripheral T-Cell Lymphoma
- 12RecruitingLast Updated: March 14, 2012Condition(s): Non-Hodgkin's Lymphoma; Hodgkin's Lymphoma
- 13RecruitingLast Updated: March 21, 2012Condition(s): T Cell Lymphoma
- 14RecruitingLast Updated: November 21, 2011Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Prolymphocytic Leukemia; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Small Intestine Lymphoma; T-cell Large Granular Lymphocyte Leukemia
- 15CompletedLast Updated: October 12, 2009Condition(s): Peripheral T-Cell Lymphomas; Non-Hodgkin Lymphoma
- 16RecruitingImmunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPLast Updated: May 4, 2012Condition(s): Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell Lymphoma
- 17RecruitingLast Updated: May 11, 2012Condition(s): Leukemia; Lymphoma
- 18CompletedLast Updated: March 14, 2012Condition(s): Lymphoma
- 19Active, not recruitingLast Updated: April 24, 2012Condition(s): Cutaneous T-Cell Lymphoma
- 20TerminatedLast Updated: December 10, 2009Condition(s): T-Cell Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Lymphoma%2C+T-Cell
